These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27128971)

  • 1. Validation of N-myristoyltransferase as Potential Chemotherapeutic Target in Mammal-Dwelling Stages of Trypanosoma cruzi.
    Herrera LJ; Brand S; Santos A; Nohara LL; Harrison J; Norcross NR; Thompson S; Smith V; Lema C; Varela-Ramirez A; Gilbert IH; Almeida IC; Maldonado RA
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004540. PubMed ID: 27128971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and genetic characterization of Trypanosoma cruzi N-myristoyltransferase.
    Roberts AJ; Torrie LS; Wyllie S; Fairlamb AH
    Biochem J; 2014 Apr; 459(2):323-32. PubMed ID: 24444291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicomponent reaction-based synthesis and biological evaluation of tricyclic heterofused quinolines with multi-trypanosomatid activity.
    Di Pietro O; Vicente-García E; Taylor MC; Berenguer D; Viayna E; Lanzoni A; Sola I; Sayago H; Riera C; Fisa R; Clos MV; Pérez B; Kelly JM; Lavilla R; Muñoz-Torrero D
    Eur J Med Chem; 2015 Nov; 105():120-37. PubMed ID: 26479031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acylation in trypanosomatids: an essential process and potential drug target.
    Goldston AM; Sharma AI; Paul KS; Engman DM
    Trends Parasitol; 2014 Jul; 30(7):350-60. PubMed ID: 24954795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using a non-image-based medium-throughput assay for screening compounds targeting N-myristoylation in intracellular Leishmania amastigotes.
    Paape D; Bell AS; Heal WP; Hutton JA; Leatherbarrow RJ; Tate EW; Smith DF
    PLoS Negl Trop Dis; 2014 Dec; 8(12):e3363. PubMed ID: 25522361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Thienopyrimidine Inhibitors of
    Bell AS; Yu Z; Hutton JA; Wright MH; Brannigan JA; Paape D; Roberts SM; Sutherell CL; Ritzefeld M; Wilkinson AJ; Smith DF; Leatherbarrow RJ; Tate EW
    J Med Chem; 2020 Jul; 63(14):7740-7765. PubMed ID: 32575985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cruzipain: An Update on its Potential as Chemotherapy Target against the Human Pathogen Trypanosoma cruzi.
    Branquinha MH; Oliveira SS; Sangenito LS; Sodre CL; Kneipp LF; d'Avila-Levy CM; Santos AL
    Curr Med Chem; 2015; 22(18):2225-35. PubMed ID: 25994861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
    Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M
    Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trypanosoma cruzi CYP51 inhibitor derived from a Mycobacterium tuberculosis screen hit.
    Chen CK; Doyle PS; Yermalitskaya LV; Mackey ZB; Ang KK; McKerrow JH; Podust LM
    PLoS Negl Trop Dis; 2009; 3(2):e372. PubMed ID: 19190730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring N-myristoyltransferase as a promising drug target against parasitic neglected tropical diseases.
    Nascimento IJDS; Cavalcanti MAT; de Moura RO
    Eur J Med Chem; 2023 Oct; 258():115550. PubMed ID: 37336067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibitors of protozoan protein N-myristoyltransferases as starting points for tropical disease medicinal chemistry programs.
    Bell AS; Mills JE; Williams GP; Brannigan JA; Wilkinson AJ; Parkinson T; Leatherbarrow RJ; Tate EW; Holder AA; Smith DF
    PLoS Negl Trop Dis; 2012; 6(4):e1625. PubMed ID: 22545171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squalene synthase as a chemotherapeutic target in Trypanosoma cruzi and Leishmania mexicana.
    Urbina JA; Concepcion JL; Rangel S; Visbal G; Lira R
    Mol Biochem Parasitol; 2002; 125(1-2):35-45. PubMed ID: 12467972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of Sulfonamide Derivatives in the Treatment of Trypanosomatid Parasites including Trypanosoma cruzi, Trypanosoma brucei, and Leishmania ssp.
    Scarim CB; Chelucci RC; Dos Santos JL; Chin CM
    Med Chem; 2020; 16(1):24-38. PubMed ID: 31218962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of thiazolidine LPSF SF29 on the growth and morphology of Trypanosoma cruzi.
    de B Moreira TL; Barbosa AF; Veiga-Santos P; Henriques C; Henriques-Pons A; Galdino SL; de Lima Mdo C; Pitta Ida R; de Souza W; de Carvalho TM
    Int J Antimicrob Agents; 2013 Feb; 41(2):183-7. PubMed ID: 23219247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting calcium homeostasis as the therapy of Chagas' disease and leishmaniasis - a review.
    Benaim B; Garcia CR
    Trop Biomed; 2011 Dec; 28(3):471-81. PubMed ID: 22433874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and selective inhibition of myristoyl-CoA:protein N-myristoyltransferase from Trypanosoma brucei and Leishmania major.
    Panethymitaki C; Bowyer PW; Price HP; Leatherbarrow RJ; Brown KA; Smith DF
    Biochem J; 2006 Jun; 396(2):277-85. PubMed ID: 16480339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of new 2,5-dihydroxybenzyl derivatives against Trypanosoma cruzi, Leishmania infantum and Leishmania braziliensis.
    Rolón M; Peixoto de Abreu Lima A; Coronel C; Vega MC; Pandolfi E; Rojas de Arias A
    J Infect Dev Ctries; 2019 Jun; 13(6):565-576. PubMed ID: 32058992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypanothione synthetase confers growth, survival advantage and resistance to anti-protozoal drugs in Trypanosoma cruzi.
    Mesías AC; Sasoni N; Arias DG; Pérez Brandán C; Orban OCF; Kunick C; Robello C; Comini MA; Garg NJ; Zago MP
    Free Radic Biol Med; 2019 Jan; 130():23-34. PubMed ID: 30359758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of pyrimidine nucleoside analogues as chemical probes to assess compound effects on the proliferation of Trypanosoma cruzi intracellular parasites.
    Sykes ML; Hilko DH; Kung LI; Poulsen SA; Avery VM
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008068. PubMed ID: 32163414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and Genetic Validation of Chemotherapeutic Targets for Chagas' Disease.
    Osorio-Méndez JF; Cevallos AM
    Front Cell Infect Microbiol; 2018; 8():439. PubMed ID: 30666299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.